• No results found

Determinants of plasma levels of von Willebrand factor and coagulation factor VIII

N/A
N/A
Protected

Academic year: 2021

Share "Determinants of plasma levels of von Willebrand factor and coagulation factor VIII"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Determinants of plasma levels of von Willebrand factor and coagulation factor VIII

Nossent, A.Y.

Citation

Nossent, A. Y. (2008, February 6). Determinants of plasma levels of von Willebrand factor and coagulation factor VIII. Retrieved from https://hdl.handle.net/1887/12592

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/12592

Note: To cite this publication please use the final published version (if applicable).

(2)

Determinants of Plasma levels of von

Willebrand Factor and Coagulation Factor VIII

(3)
(4)

Determinants of Plasma levels of von

Willebrand Factor and Coagulation Factor VIII

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden

op gezag van de Rector Magnificus prof.mr. P.F. van der Heijden, volgens besluit van het College voor Promoties

te verdedigen op 6 februari 2008 klokke 13:45 uur

door

Anne Yaël Nossent

geboren te Hattem

in 1978

(5)

Promotiecommissie

Promotores: Prof. dr. R.M. Bertina

Prof. dr. F.R. Rosendaal

Co-promotor: Dr. H.C.J. Eikenboom

Referent: Prof. dr. M.M. Levi (Universiteit van Amsterdam)

Overige Leden: Prof. dr. J.P. Vandenbroucke Prof. dr. J.W. Jukema

Prof. dr. A.J. Rabelink

The research described in this thesis has been supported financially by grants from the Dutch Heart Foundation (NHS 2002T030), the Thrombosis Foundation Netherlands (TSN 2005-03) and the Leducq Foundation (Paris, France) for the development of Transatlantic Networks of Excellence in Cardiovascular Research and was performed at the Haemostasis and Thrombosis Research Center, Department of Haematology (now the Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis) of the Leiden University Medical Center in Leiden, the Netherlands.

Publication of this thesis was financially supported by the ‘Hettema-Heerema- Leen’.

Further financial support by the Netherlands Heart Foundation and the Thrombosis Foundation Netherlands for publication of this thesis is gratefully acknowledged.

Cover design: The cover of this thesis was designed by Albert Jan Nossent and features the newly renovated ‘Hezenberger Sluis’ in ‘Het Apeldoorns Kanaal’

near the city of Hattem in Gelderland, the Netherlands.

Lay-out: The lay-out of this thesis was performed by Dr. ing. Shirley Uitte de Willige.

© 2008 A.Y. Nossent ISBN:978-87-992288-0-5

Printed by Printpartners Ipskamp in Enschedé

(6)

Table of Contents

Chapter 1 Introduction 9

Chapter 2 Plasma Coagulation Factor Levels in Venous Thrombosis 19 Chapter 3 Von Willebrand factor and its Propeptide: The Influence

of Secretion and Clearance on Protein Levels and the Risk of Venous Thrombosis

43

Chapter 4a Haplotypes Encoding the Factor VIII 1241Glu Variation, Factor VIII Levels and the Risk of Venous Thrombosis

63

Chapter 4b Haplotypes Encoding the Factor VIII 1241Glu Variation and the Risk of Myocardial Infarction

83

Chapter 5 Beta 2 Adrenergic Receptor Polymorphisms: Association with Factor VIII and von Willebrand Factor Levels and the Risk of Venous Thrombosis

93

Chapter 6 Vasopressin 2 Receptor Gene Variations and the Regulation of Levels of von Willebrand Factor and Factor VIII and the Risk of Venous Thrombosis

101

Chapter 7 Plasma Levels of von Willebrand Factor Propeptide, von Willebrand Factor and Coagulation Factor VIII in Carriers and Patients with Nephrogenic Diabetes Insipidus

121

Chapter 8 Associations of Aquaporin 2 Gene Variations with Plasma Levels of von Willebrand Factor and Factor VIII and the Risk of Venous Thrombosis

143

Chapter 9 Associations of Blood Pressure and Antihypertensive Drugs with Plasma Levels of Coagulation Factor VIII

161

Chapter 10 Summary & Discussion 181

Chapter 11 Samenvatting 199

Nawoord 207

Curriculum Vitae 211

(7)

Referenties

GERELATEERDE DOCUMENTEN

For instance, the risks of both venous and arterial thrombosis are increased by elevated plasma levels of von Willebrand factor (VWF) and coagulation factor VIII (FVIII) 4.. VWF is

High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene.. De Visser

We measured VWF propeptide levels in the LETS to study the effects of VWF secretion and clearance on levels of VWF and FVIII and on the risk of venous thrombosis.. To study

Several studies have shown that elevated levels of coagulation factor VIII (FVIII) are an important risk factor of venous thrombosis.. This risk remains after adjusting for the

To investigate whether these three FVIII gene haplotypes also affect the risk of arterial thrombosis, we studied the effects of these haplotypes in two population based

High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene.. Koster T,

Three AVPR2 SNPs, a-245c, G12E and S331S were in strong linkage disequilibrium and were associated with an increase in plasma levels of VWF propeptide, VWF and FVIII

Several studies have shown that elevated plasma levels of coagulation factor VIII (FVIII) are a risk factor of venous thrombosis 1-7.. FVIII levels strongly depend on levels of